Application of Jatiphala Lepa in the management of Vyanga with special reference to Melasma

To evaluate the efficacy of Jatiphala Lepa on Vyanga w.s.r to Melasma-An experimental pilot study - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078013

Enrollment

Registered

2024-12-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere Health Condition 2: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pigmentation caused by over exposure to sunlight 2. Due to hormonal changes, as an after effect of pregnancy and menopause 3. Having a positive family history 4. Aged Between 25 to 50 years

Exclusion criteria

Exclusion criteria: 1. Pigmentation seen due to burns 2. Medication allergy

Design outcomes

Primary

Measure	Time frame
The effect of Jatiphala Lepa on Vyanga wsr to Melasma will be assessed using MASI score. This will be helpful to see the drug effect and its imppact on patients healthTimepoint: Assessment will be done on baseline i.e, 0th day and 29th day.	—

Secondary

Measure	Time frame
It heps in overcoming the emotional distress and impacting quality of lifeTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Pooja BA

Sushrutha Ayurvedic Medical College and Hospital Bengaluru

drpoojaba@gmail.com9902209309

Outcome results